Kanayo Satoh
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.
Journal: Nature communications
Published: February 17, 2026
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.
Journal: Nature communications
Published: February 17, 2026
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: June 18, 2024
Differential interaction with TREM2 modulates microglial uptake of modified Aβ species.
Journal: Glia
Published: June 17, 2021
Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Aβ aggregation.
Journal: The Journal of biological chemistry
Published: February 05, 2021
SUMO1 impact on Alzheimer disease pathology in an amyloid-depositing mouse model.
Journal: Neurobiology of disease
Published: March 30, 2017
ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing.
Journal: The Journal of biological chemistry
Published: March 27, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026